Advances in Microbiome Detection Technologies and Application in Antirheumatic Drug Design

Xin Wu1, Xiang Chen2, Xiaochen Lyu2

  • 1Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai, China.

Insights

Gut microbiome alterations are linked to rheumatic diseases like AS and SLE. Advances in metagenomics help identify these changes, offering potential for new diagnostic and therapeutic strategies targeting gut bacteria.

Area of Science:

  • Microbiology
  • Immunology
  • Genetics

Background:

  • Rheumatic diseases, including Ankylosing spondylitis (AS), gout, and Systemic lupus erythematosus (SLE), are chronic inflammatory and autoimmune conditions.
  • The etiology of rheumatic diseases is complex, involving genetic and environmental factors, with a growing emphasis on the gut microbiome's role.
  • Dysbiosis, or an imbalance in gut microbiota, is increasingly implicated in the pathogenesis of these diseases.

Purpose of the Study:

  • To review advances in microbial profiling technologies, particularly metagenomics, for studying the gut microbiome in rheumatic diseases.
  • To highlight resources for accurate taxonomic assignment of metagenomic data.
  • To summarize reported alterations in gut microbiota signatures associated with rheumatic diseases and discuss their potential for diagnostics and therapeutics.

Main Methods:

  • Review of next-generation sequencing-based microbial profiling technologies, focusing on metagenomics.
  • Analysis of existing literature on gut microbiota composition and function in patients with rheumatic diseases.
  • Discussion of computational tools and databases for metagenomic data analysis.

Main Results:

  • Metagenomic studies have revealed significant alterations in the composition and function of the gut microbiota in patients with rheumatic diseases.
  • Specific gut microbial signatures have been identified across various rheumatic conditions.
  • Treatment strategies, including disease-modifying antirheumatic drugs (DMARDs), can modulate the gut microbiome and impact disease symptoms.

Conclusions:

  • Gut dysbiosis plays a pivotal role in the pathogenesis of rheumatic diseases.
  • Advances in metagenomics provide powerful tools for understanding these microbial alterations.
  • Targeting the gut microbiome offers promising avenues for developing novel diagnostic biomarkers and therapeutic interventions for rheumatic diseases.

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
685
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
334
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
306
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.9K
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
395
Applications of Molecular Taxonomy01:20

Applications of Molecular Taxonomy

Molecular taxonomy has revolutionized the understanding and classification of bacteria, providing precise insights into their diversity, evolutionary relationships, and ecological roles. By utilizing molecular techniques such as DNA sequencing and fingerprinting, researchers have made significant strides in various fields related to bacterial studies.Resolving Taxonomic AmbiguitiesMolecular taxonomy has been instrumental in distinguishing closely related bacterial species initially thought to...
320